Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM

• Published in: Clinical & translational oncology Vol. 22; no. 5; pp. 647 - 662
• Main Authors: Vera, R., González-Flores, E., Rubio, C., Urbano, J., Valero Camps, M., Ciampi-Dopazo, J. J., Orcajo Rincón, J., Morillo Macías, V., Gomez Braco, M. A., Suarez-Artacho, G.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.05.2020
• Subjects: Algorithms; Clinical Guides in Oncology; Colorectal Neoplasms - pathology; Combined Modality Therapy; Consensus; Hepatectomy; Humans; Liver Neoplasms - secondary; Liver Neoplasms - therapy; Medical Oncology - methods; Medical Oncology - organization & administration; Medicine; Medicine & Public Health; Oncology; Patient Care Team - standards; Spain; Spain; Locoregional therapies; Liver metastases; Chemotherapy; Surgery; Consensus; Colorectal cancer
• ISSN: 1699-048X; 1699-3055
• DOI: 10.1007/s12094-019-02182-z

Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by cancer. Nearly 20% of patients with CRC will have metastases at the time of diagnosis, and more than 50% of patients with CRC develop metastatic disease during the course of their disease. A group of experts from the Spanish Society of Medical Oncology, the Spanish Association of Surgeons, the Spanish Society of Radiation Oncology, the Spanish Society of Vascular and Interventional Radiology, and the Spanish Society of Nuclear Medicine and Molecular Imaging met to discuss and provide a multidisciplinary consensus on the management of liver metastases in patients with CRC. The group defined the different scenarios in which the disease can present: fit or unfit patients with resectable liver metastases, patients with potential resectable liver metastases, and patients with unresectable liver metastases. Within each scenario, the different strategies and therapeutic approaches are discussed.